A New Approach to
Autism Detection
Using cutting edge technology and decades of medical expertise to find innovative ways
to detect autism spectrum disorder easier, faster, and better
Our Vision
Our vision at Appiture Biotechnologies is a future more reliant on physical indicators of ASD risk. Through the integration of technology and medicine, we are developing technology to help doctors screen for ASD using an objective physical biomarker in the context of other developmental indicators of overall health.
Currently, diagnosing autism spectrum disorder (ASD) is highly reliant on behavioral screening tools which can often introduce subjectivity into the screening procedure. Inconsistency in tool use and the introduction of bias through subjective assessment limit the ability of doctors to get an accurate picture of ASD risk.
To date, no objective first-line ASD screening tool exists for use by doctors.
A Story of ASD
“Our personal journey into this world of autism began just over eight years ago with the birth of our son, Perry. Since the beginning, he struggled immensely. The first thing we noticed was that he seemed very restless. He was always unsettled. He had a lack of recognition in his eye. He didn’t eat. He didn’t sleep. As each day passed, we recognized more ‘red flag’ characteristics of autism with repetitive behaviors, speech/sound delays and more.”
“I put Perry’s name on the waiting list of every developmental pediatrician… I was told there would be a minimum 6 month wait time… we finally got an appointment with a developmental pediatrician… The doctor confirmed what I already knew: Perry has autism.”
“I cried all the way home. I cried for 2 days, hoping and praying that I would be able to provide this child everything he needed… I could not afford to make the wrong choice. My son’s future depended on it.”
Source: National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention
Challenges with Autism Spectrum Disorder
Despite decades of research and efforts to improve early detection, many challenges remain to effective ASD screening. Better screening leads to early intervention, improving health outcomes.
most children are not diagnosed with ASD until after age 4 years.
meaning it is more "plastic" or changeable. Because of this plasticity, treatments have a
better chance of being effective in the longer term.
National Institute of Child Health
and Human Development